EPAM vs. DOX, CTSH, AZPN, HCP, VRSN, ZS, WIT, WWD, SNX, and BRKR
Should you be buying EPAM Systems stock or one of its competitors? The main competitors of EPAM Systems include Amdocs (DOX), Cognizant Technology Solutions (CTSH), Aspen Technology (AZPN), HashiCorp (HCP), VeriSign (VRSN), Zscaler (ZS), Wipro (WIT), Woodward (WWD), TD SYNNEX (SNX), and Bruker (BRKR). These companies are all part of the "computer and technology" sector.
Amdocs (NASDAQ:DOX) and EPAM Systems (NYSE:EPAM) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, community ranking, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.
Amdocs has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500. Comparatively, EPAM Systems has a beta of 1.46, indicating that its stock price is 46% more volatile than the S&P 500.
In the previous week, EPAM Systems had 9 more articles in the media than Amdocs. MarketBeat recorded 15 mentions for EPAM Systems and 6 mentions for Amdocs. EPAM Systems' average media sentiment score of 1.28 beat Amdocs' score of -0.07 indicating that Amdocs is being referred to more favorably in the media.
Amdocs received 18 more outperform votes than EPAM Systems when rated by MarketBeat users. However, 73.68% of users gave EPAM Systems an outperform vote while only 72.42% of users gave Amdocs an outperform vote.
92.0% of Amdocs shares are held by institutional investors. Comparatively, 91.6% of EPAM Systems shares are held by institutional investors. 15.4% of Amdocs shares are held by insiders. Comparatively, 4.3% of EPAM Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Amdocs has a net margin of 10.62% compared to Amdocs' net margin of 9.28%. EPAM Systems' return on equity of 17.85% beat Amdocs' return on equity.
Amdocs currently has a consensus target price of $104.83, suggesting a potential upside of 28.24%. EPAM Systems has a consensus target price of $282.81, suggesting a potential upside of 50.59%. Given Amdocs' higher possible upside, analysts plainly believe EPAM Systems is more favorable than Amdocs.
Amdocs has higher revenue and earnings than EPAM Systems. Amdocs is trading at a lower price-to-earnings ratio than EPAM Systems, indicating that it is currently the more affordable of the two stocks.
Summary
Amdocs and EPAM Systems tied by winning 9 of the 18 factors compared between the two stocks.
Get EPAM Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for EPAM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EPAM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
EPAM Systems Competitors List
Related Companies and Tools
